Celera Licenses Decode’s Heart, Diabetes Markers

Celera plans to use the SNPs to develop personalized risk tests for heart attack, stroke, and type 2 diabetes.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.